Patents by Inventor Robert A. Archer

Robert A. Archer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4102902
    Abstract: An optically active 4-(4-substituted-2,6-dihydroxyphenyl)-6,6-dimethyl-2-norpinanone is reacted with a protonic acid to provide an optical isomer of a cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibe nzo[b,d]pyran-9-one. Reaction of said norpinanone with a Lewis acid provides an optical isomer of trans-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-di benzo[b,d]pyran-9-one. The optically active norpinanones are prepared by reaction of a 5-substituted-resorcinol with an optically active 6,6-dimethyl-2,4-diacetoxy-2-norpinene or an optically active 6,6-dimethyl-2,2-diacetoxy-3-norpinene, which compounds are derived from optically active .beta.-pinenes.
    Type: Grant
    Filed: November 10, 1976
    Date of Patent: July 25, 1978
    Assignee: Eli Lilly and Company
    Inventors: Robert A. Archer, William A. Day
  • Patent number: 4088777
    Abstract: Use of 1-hydroxy-3-alkyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones as anticonvulsant drugs.
    Type: Grant
    Filed: February 17, 1976
    Date of Patent: May 9, 1978
    Assignee: Eli Lilly and Company
    Inventors: Robert A. Archer, Louis Lemberger
  • Patent number: 4087547
    Abstract: Use of 1-hydroxy-3-alkyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones in treatment of glaucoma.
    Type: Grant
    Filed: February 17, 1976
    Date of Patent: May 2, 1978
    Assignee: Eli Lilly and Company
    Inventors: Robert A. Archer, Louis Lemberger
  • Patent number: 4087546
    Abstract: Use of 1-hydroxy-3-alkyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs.
    Type: Grant
    Filed: February 17, 1976
    Date of Patent: May 2, 1978
    Assignee: Eli Lilly and Company
    Inventors: Robert A. Archer, Louis Lemberger
  • Patent number: 4087545
    Abstract: Use of 1-hydroxy-3-alkyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones as antiemetic drugs.
    Type: Grant
    Filed: February 17, 1976
    Date of Patent: May 2, 1978
    Assignee: Eli Lilly and Company
    Inventors: Robert A. Archer, Louis Lemberger
  • Patent number: 4075230
    Abstract: Reaction of a 5-substituted resorcinol with optically active apoverbenone in the presence of aluminum chloride affords an optically active trans-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-di benzo[b,d]pyran-9-one.
    Type: Grant
    Filed: November 10, 1976
    Date of Patent: February 21, 1978
    Assignee: Eli Lilly and Company
    Inventors: Robert A. Archer, William A. Day
  • Patent number: 4064009
    Abstract: 1-Hydroxy-9-keto-3-alkyl-dibenzo[b,d]pyrans or 1,9-dihydroxy-3-alkyl-dibenzo[b,d]pyrans are oxygenated on the penultimate carbon of the alkyl side chain by fermentation with a strain of the micro-organism Bacillus cereus.
    Type: Grant
    Filed: June 9, 1976
    Date of Patent: December 20, 1977
    Assignee: Eli Lilly and Company
    Inventors: David S. Fukuda, Bernard J. Abbott, Robert A. Archer
  • Patent number: 4024275
    Abstract: 1,9-Dihydroxy-3-alkyl-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyrans, are useful as hypotensive agents, and can be employed to treat hypertension.
    Type: Grant
    Filed: April 2, 1976
    Date of Patent: May 17, 1977
    Assignee: Eli Lilly and Company
    Inventor: Robert A. Archer
  • Patent number: 4014028
    Abstract: A bifilar helical antenna which will radiate or receive in the backfire mode. The antenna consists of two interlaced helixes fed at the tip. Each helix is fed by a transmission line with energy of equal amplitude but 180.degree. out of phase. Optionally the helixes may be connected to a ground plane at the far end for mechanical stability. For the same reason an insulating right cylinder may be used to support the helixes. The two helixes have such a diameter and such a pitch or pitch distance that the currents flowing from their terminals to the far end are out of phase while the currents flowing in the reverse direction are in phase to provide a fast pseudo wave structure.
    Type: Grant
    Filed: August 11, 1975
    Date of Patent: March 22, 1977
    Assignee: TRW Inc.
    Inventors: John A. Cone, Robert A. Archer, Edward R. Pacheco, Creath E. Peyton
  • Patent number: 3987188
    Abstract: Use of 1-hydroxy-3-alkyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones as sedative drugs.
    Type: Grant
    Filed: October 30, 1975
    Date of Patent: October 19, 1976
    Assignee: Eli Lilly and Company
    Inventor: Robert A. Archer
  • Patent number: 3968125
    Abstract: 1,9-Dihydroxy-3-alkyl-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyrans, useful as hypotensive agents, as psychotropic drugs, particularly as anti-anxiety and/or antidepressant drugs, and as sedative and/or analgesic drugs.
    Type: Grant
    Filed: November 5, 1973
    Date of Patent: July 6, 1976
    Assignee: Eli Lilly and Company
    Inventor: Robert A. Archer
  • Patent number: 3953603
    Abstract: Use of 1-hydroxy-3-alkyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones as psychotropic drugs, particularly as anti-depressant drugs, and pharmaceutical compositions containing same.
    Type: Grant
    Filed: May 1, 1975
    Date of Patent: April 27, 1976
    Assignee: Eli Lilly and Company
    Inventor: Robert A. Archer
  • Patent number: 3944673
    Abstract: Use of 1-hydroxy-3-alkyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones as an analgesic drug and pharmaceutical compositions containing same.
    Type: Grant
    Filed: May 23, 1975
    Date of Patent: March 16, 1976
    Assignee: Eli Lilly and Company
    Inventor: Robert A. Archer